RS
Rama Subrahmanyam Sana
About Rama Subrahmanyam Sana
Data last updated:
Rama Subrahmanyam Sana is a Director at Spanus Pharmaceuticals Private Limited (since 2019) and Director at Layspan Pharmaceuticals Private Limited (since 2023). The companies operate in Chemicals and Materials, Pharma and Chemicals. The largest current company by reported revenue is Spanus Pharmaceuticals Private Limited at ₹2.83 Cr (FY 2022). Earlier, Rama Subrahmanyam Sana was a Director at Sarath Meditech Private Limited (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spanus Pharmaceuticals Private Limited U24239TG2019PTC130023 | Director | 25 Jan 2019 | 2019 | ₹2.83 Cr (FY 2022) | Active |
| Layspan Pharmaceuticals Private Limited U46497TS2023PTC176849 | Director | 06 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sarath Meditech Private Limited U24100TG2022PTC166614 | Director | 13 Sep 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rama Subrahmanyam Sana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sri Chandana Modukuri | 07689464 | Spanus Pharmaceuticals Private Limited | Director |
| Udaya Kiran Perla | 07313247 | Spanus Pharmaceuticals Private Limited | Managing Director |
| Srinivasa Babu Yadala | 08488893 | Layspan Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rama Subrahmanyam Sana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rama Subrahmanyam Sana
Rama Subrahmanyam Sana currently holds 2 directorships: Spanus Pharmaceuticals Private Limited (Director, since 25 Jan 2019, revenue ₹2.83 Cr (FY 2022)); Layspan Pharmaceuticals Private Limited (Director, since 06 Sep 2023).
Rama Subrahmanyam Sana was first appointed on 25 Jan 2019 as Director at Spanus Pharmaceuticals Private Limited. The most recent appointment on record is 06 Sep 2023 at Layspan Pharmaceuticals Private Limited.
Rama Subrahmanyam Sana held 1 earlier board appointment: Sarath Meditech Private Limited (Director, 13 Sep 2022 to 31 May 2025).
The current boards of Rama Subrahmanyam Sana's companies include Sri Chandana Modukuri (Spanus Pharmaceuticals Private Limited), Udaya Kiran Perla (Spanus Pharmaceuticals Private Limited), Srinivasa Babu Yadala (Layspan Pharmaceuticals Private Limited).